InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector

By WebmasterJanuary 16, 2013November 1st, 2024No Comments

InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector
Read more here

Previous PostNuPathe Wins U.S. FDA Approval for Migraine Skin Patch
Next PostFDA is Readying to Rule on NuPathe’s Revised Application for its Patch to Treat Migraines